BID | 200.00 | ASK | 222.69 | ||
Open | 217.45 | Previous Close | 216.52 | ||
Pre-Market | - | After-Market | 218.89 | ||
- - | - -% |
Target Price | 239.10 | Analyst Rating | Moderate Buy 1.60 | |
Potential % | 9.23 | Finscreener Ranking | ★ 41.79 | |
Insiders Trans % 3/6/12 mo. | 76/70/-17 | Value Ranking | + 37.19 | |
Insiders Value % 3/6/12 mo. | 97/82/-2 | Growth Ranking | ★+ 40.10 | |
Insiders Shares Cnt. % 3/6/12 mo. | 97/85/7 | Income Ranking | ★ 31.42 | |
Price Range Ratio 52W % | 47.51 | Earnings Rating | Sell | |
Market Cap | 62.83B | Earnings Date | 22nd Jul 2022 | |
Alpha | 0.00 | Standard Deviation | 0.11 | |
Beta | 1.66 |
Today's Price Range 216.92219.02 | 52W Range 164.47279.02 | 5 Year PE Ratio Range 2.5020.90 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 2.86% | ||
1 Month | 29.28% | ||
3 Months | 1.85% | ||
6 Months | -7.86% | ||
1 Year | -10.73% | ||
3 Years | 71.14% | ||
5 Years | 175.78% | ||
10 Years | 834.38% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -77.49 | |||
ROE last 12 Months | -309.75 | |||
ROA (5Y Avg) | 5.63 | |||
ROA last 12 Months | 13.83 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | 5.19 | |||
Return on invested Capital Q | 5.19 | |||
Return on invested Capital Y | - | |||
Assets Turnover | 1.20 | |||
Receivables Turnover | 7.80 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
10.40 | ||||
292.01 | ||||
1.03 | ||||
8.70 | ||||
15.30 | ||||
24.77 | ||||
-16.89 | ||||
-12.82 | ||||
101.99B | ||||
Forward PE | 11.80 | |||
PEG | 0.94 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.10 | ||||
1.50 | ||||
0.99 | ||||
132.80 | ||||
6.70 | ||||
Leverage Ratio | -27.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
83.40 | ||||
18.20 | ||||
23.10 | ||||
12.70 | ||||
12.10 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
60.11B | ||||
209.41 | ||||
6.26 | ||||
6.71 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.03 | ||||
2.24 | ||||
2.72 | ||||
- | ||||
Payout ratio | 6.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2022 | 3.67 | 4.21 | 14.71 |
Q01 2022 | 4.27 | 4.12 | -3.51 |
Q04 2021 | 4.55 | 4.42 | -2.86 |
Q03 2021 | 4.10 | 4.57 | 11.46 |
Q02 2021 | 3.17 | 4.37 | 37.85 |
Q01 2021 | 3.35 | 4.14 | 23.58 |
Q04 2020 | 3.63 | 4.13 | 13.77 |
Q03 2020 | 2.69 | 1.92 | -28.62 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
9/2022 QR | 3.94 | -15.09 | Negative |
12/2022 QR | 4.68 | -11.20 | Negative |
12/2022 FY | 16.42 | -3.13 | Negative |
12/2023 FY | 18.02 | -10.84 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 3.67 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | 8.60 |
Volume Overview | |
---|---|
Volume | 668.34K |
Shares Outstanding | 287.02K |
Shares Float | 223.69M |
Trades Count | 13.70K |
Dollar Volume | 145.86M |
Avg. Volume | 1.45M |
Avg. Weekly Volume | 939.69K |
Avg. Monthly Volume | 1.54M |
Avg. Quarterly Volume | 1.85M |
HCA Healthcare Inc. (NYSE: HCA) stock closed at 218.89 per share at the end of the most recent trading day (a 1.09% change compared to the prior day closing price) with a volume of 668.34K shares and market capitalization of 62.83B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 275000 people. HCA Healthcare Inc. CEO is Samuel N. Hazen.
The one-year performance of HCA Healthcare Inc. stock is -10.73%, while year-to-date (YTD) performance is -14.8%. HCA stock has a five-year performance of 175.78%. Its 52-week range is between 164.47 and 279.02, which gives HCA stock a 52-week price range ratio of 47.51%
HCA Healthcare Inc. currently has a PE ratio of 10.40, a price-to-book (PB) ratio of 292.01, a price-to-sale (PS) ratio of 1.03, a price to cashflow ratio of 8.70, a PEG ratio of 2.32, a ROA of 13.83%, a ROC of 5.19% and a ROE of -309.75%. The company’s profit margin is 12.10%, its EBITDA margin is 23.10%, and its revenue ttm is $60.10 Billion , which makes it $209.41 revenue per share.
Of the last four earnings reports from HCA Healthcare Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $3.67 for the next earnings report. HCA Healthcare Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for HCA Healthcare Inc. is Moderate Buy (1.6), with a target price of $239.1, which is +9.23% compared to the current price. The earnings rating for HCA Healthcare Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
HCA Healthcare Inc. has a dividend yield of 1.03% with a dividend per share of $2.24 and a payout ratio of 6.00%.
HCA Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 15.29, ATR14 : 9.57, CCI20 : 84.39, Chaikin Money Flow : -0.12, MACD : 8.63, Money Flow Index : 71.63, ROC : 6.95, RSI : 86.33, STOCH (14,3) : 96.28, STOCH RSI : 0.51, UO : 50.55, Williams %R : -3.72), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of HCA Healthcare Inc. in the last 12-months were: Andrea B. Smith (Buy at a value of $247 815), Christopher F. Wyatt (Sold 2 100 shares of value $531 174 ), Deborah M. Reiner (Sold 2 052 shares of value $505 261 ), Jane D. Englebright (Option Excercise at a value of $534 931), Jane D. Englebright (Sold 3 364 shares of value $839 689 ), Jennifer Berres (Option Excercise at a value of $808 545), Jennifer L. Berres (Option Excercise at a value of $808 545), Jennifer L. Berres (Sold 2 358 shares of value $516 087 ), Jon M. Foster (Option Excercise at a value of $1 600 998), Jon M. Foster (Sold 16 294 shares of value $3 937 298 ), Joseph A. Sowell (Option Excercise at a value of $1 121 298), Joseph A. Sowell (Sold 33 720 shares of value $8 853 808 ), Kathleen M. Whalen (Option Excercise at a value of $504 300), Kathleen M. Whalen (Sold 4 315 shares of value $1 063 288 ), Kathryn A. Torres (Option Excercise at a value of $1 142 748), Michael R. McAlevey (Buy at a value of $242 602), Patricia F Elcan (Buy at a value of $64 565), Phillip G. Billington (Option Excercise at a value of $344 250), Phillip G. Billington (Sold 8 252 shares of value $2 032 096 ), Sammie S. Mosier (Option Excercise at a value of $0), Samuel N. Hazen (Option Excercise at a value of $0), Thomas F. Frist (Buy at a value of $37 766 000), William B. Rutherford (Sold 30 000 shares of value $7 500 000 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Strong Buy |
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2020, the firm owned and operated 185 hospitals, 121 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
CEO: Samuel N. Hazen
Telephone: +1 615 344-9551
Address: One Park Plaza, Nashville 37203, TN, US
Number of employees: 275 000
Wed, 27 Jul 2022 03:26 GMT Analysts Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), HCA Healthcare (HCA) and Universal Health (UHS)
- TipRanks. All rights reserved.Mon, 25 Jul 2022 14:07 GMT Heres Why HCA Healthcare Shares Rose 11.4%
- TipRanks. All rights reserved.Mon, 25 Jul 2022 12:40 GMT HCA Healthcare (HCA) Receives a Buy from SVB Securities
- TipRanks. All rights reserved.Mon, 25 Jul 2022 12:35 GMT Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Zai Lab (ZLAB)
- TipRanks. All rights reserved.Mon, 11 Jul 2022 12:33 GMT Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), SAGE Therapeutics (SAGE) and Alector (ALEC)
- TipRanks. All rights reserved.Tue, 21 Jun 2022 12:33 GMT Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Amedisys (AMED) and ACADIA Pharmaceuticals (ACAD)
- TipRanks. All rights reserved.Tue, 26 Apr 2022 12:48 GMT Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Gossamer Bio (GOSS)
- TipRanks. All rights reserved.Mon, 25 Apr 2022 16:37 GMT HCA Healthcare (HCA) Receives a Hold from Wells Fargo
- TipRanks. All rights reserved.Mon, 25 Apr 2022 12:54 GMT HCA Healthcare (HCA) Receives a Buy from RBC Capital
- TipRanks. All rights reserved.Mon, 25 Apr 2022 01:18 GMT HCA Healthcare (HCA) Receives a Hold from Barclays
- TipRanks. All rights reserved.Wed, 05 Jan 2022 14:11 GMT Jefferies Believes HCA Healthcare (HCA) Still Has Room to Grow
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.